Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001381676 | SCV001580169 | pathogenic | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2024-12-31 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile1048Metfs*40) in the FBN1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FBN1 are known to be pathogenic (PMID: 17657824, 19293843). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with Marfan syndrome (PMID: 21542060). ClinVar contains an entry for this variant (Variation ID: 549132). For these reasons, this variant has been classified as Pathogenic. |
Centre of Medical Genetics, |
RCV000663604 | SCV002025565 | pathogenic | Marfan syndrome | 2021-03-01 | criteria provided, single submitter | research | PM2, PVS1, PP1, PP4 |
Center for Medical Genetics Ghent, |
RCV000663604 | SCV000786924 | likely pathogenic | Marfan syndrome | 2017-11-07 | no assertion criteria provided | clinical testing |